Neurotoxicity of the antineoplastic drugs: "Doxorubicin" as an example.

Abal M, Andreu JM, Barasoain I (2003) Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action. Curr Cancer Drug Targets 3(3):193–203

pubmed: 12769688 doi: 10.2174/1568009033481967

Abd El-Aal SA, Abd Elrahman M, Reda AM et al (2022) Galangin mitigates DOX-induced cognitive impairment in rats: implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-α/MAPKs/RIPK/MLKL/BDNF. Neurotoxicol 92:77–90.

doi: 10.1016/j.neuro.2022.07.005

Abdelkarim M, Perez-Davalos L, Abdelkader Y et al (2023) Critical design parameters to develop biomimetic organ-on-a-chip models for the evaluation of the safety and efficacy of nanoparticles. Expert Opin Drug Deliv 20(1):13–30

pubmed: 36440475 doi: 10.1080/17425247.2023.2152000

Adekola KU, Dalva Aydemir S, Ma S, Zhou Z, Rosen ST, Shanmugam M (2015) Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin. Leuk Lymphoma 56(2):450–459

pubmed: 24828872 doi: 10.3109/10428194.2014.922180

Akbar S, Subhan F, Shahid M, Wadood A et al (2020) 6-Methoxyflavanone abates cisplatin-induced neuropathic pain apropos anti-inflammatory mechanisms: a behavioral and molecular simulation study. Eur J Pharmacol 872:172972

pubmed: 32006559 doi: 10.1016/j.ejphar.2020.172972

Alcindor T, Beauger N (2011) Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol 18(1):18–25

pubmed: 21331278 pmcid: 3031353 doi: 10.3747/co.v18i1.708

Alharbi I, Alharbi H, Almogbel Y et al (2020) Effect of metformin on doxorubicin-induced memory dysfunction. Brain sci 10(3):152

pubmed: 32156040 pmcid: 7139300 doi: 10.3390/brainsci10030152

Alhowail AH, Bloemer J, Majrashi M et al (2019) Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation. Toxicol Mech Methods 29(6):457–466

pubmed: 31010378 doi: 10.1080/15376516.2019.1600086

Ali MA, Menze ET, Tadros MG, Tolba MF (2020) Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: emphasis on the modulation of oxidative stress and neuroinflammation. Neuropharmacol 181:108334

doi: 10.1016/j.neuropharm.2020.108334

Alrushaid S, Zhao Y, Sayre CL, Maayah ZH et al (2017) Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. Drug Delivery Translational Res 7:582–597

doi: 10.1007/s13346-017-0379-2

Alsikhan RS, Aldubayan MA, Almami IS, Alhowail AH (2023) Protective effect of galantamine against doxorubicin-induced neurotoxicity. Brain Sci 13(6):971

pubmed: 37371449 pmcid: 10296141 doi: 10.3390/brainsci13060971

Aluise CD, Miriyala S, Noel T, Sultana R et al (2011) 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biol Med 50(11):1630–1638

doi: 10.1016/j.freeradbiomed.2011.03.009

Angelini A, Conti P, Ciofani G, Cuccurullo F, Di Ilio C (2013) Modulation of multidrug resistance P-glycoprotein activity by antiemetic compounds in human doxorubicin-resistant sarcoma cells (MES-SA/Dx-5): implications on cancer therapy. J Biol Regul Homeost Agents 27(4):1029–1037

pubmed: 24382184

Argenziano M, Gigliotti CL, Clemente N, Boggio E, Ferrara B, Trotta F, Pizzimenti S, Barrera G et al (2020) Improvement in the Anti-tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in mice bearing breast tumor models. Cancers 12(1):162. https://doi.org/10.3390/cancers12010162

doi: 10.3390/cancers12010162 pubmed: 31936526 pmcid: 7016577

Argyriou AA, Kyritsis AP, Makatsoris T, Kalofonos HP (2014) Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manag res 135–147

Armenian S, Bhatia S (2018) Predicting and preventing anthracycline-related cardiotoxicity. Am Soc Clin Oncol Educational Book 38:3–12

pubmed: 30231396 doi: 10.1200/EDBK_100015

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A et al (2017) Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol 56(2):190–197

pubmed: 28055266 doi: 10.1080/0284186X.2016.1266089

Ashley N, Poulton J (2009) Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs. Biochem biophysic res comm378(3), 450–455

Asma ST, Acaroz U, Imre K, Morar A, Shah SRA et al (2022) Natural products/bioactive compounds as a source of anticancer drugs. Cancers 14(24):6203

pubmed: 36551687 pmcid: 9777303 doi: 10.3390/cancers14246203

Aviello G, Knaus UG (2017) ROS in gastrointestinal inflammation: rescue or sabotage? Br J Pharmacol 174(12):1704–1718

pubmed: 26758851 doi: 10.1111/bph.13428

Bagues A, López-Tofiño Y, Llorente-Berzal A, Abalo R (2022) Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models. Behav Pharmacol 33(23):105–129

pubmed: 35045012 doi: 10.1097/FBP.0000000000000667

Bai RY, Staedtke V, Aprhys CM, Gallia GL, Riggins GJ (2011) Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neurooncology 13(9):974–982

Beji S, D’Agostino M, Gambini E, Sileno S et al (2021) Doxorubicin induces an alarmin-like TLR4-dependent autocrine/paracrine action of Nucleophosmin in human cardiac mesenchymal progenitor cells. BMC biol 19(1):124

pubmed: 34134693 pmcid: 8210386 doi: 10.1186/s12915-021-01058-5

Bientinesi E, Lulli M, Becatti M, Ristori S, Margheri F, Monti D (2022) Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: the role of Quercetin in modulating these processes. Mech Ageing Dev 206:111689

pubmed: 35728630 doi: 10.1016/j.mad.2022.111689

Bonavida B, Bharti AC, Aggarwal BB (2017) Role of nutraceuticals in cancer chemosensitization. Academic

Borai IH, Ezz MK, Rizk MZ, Aly HF et al (2017) Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl

doi: 10.1016/j.biopha.2017.07.038

Brüning A, Burger P, Vogel M, Rahmeh M, Gingelmaier A et al (2009) Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis. Cancer Biol Ther 8(3):226–232

pubmed: 19106637 doi: 10.4161/cbt.8.3.7339

Bulbake U, Doppalapudi S, Kommineni N, Khan W (2017) Liposomal formulations in clinical use: an updated review. Pharmaceutics 9(2):12

pubmed: 28346375 pmcid: 5489929 doi: 10.3390/pharmaceutics9020012

Cardinale D, Iacopo F, Cipolla CM (2020) Cardiotoxicity of anthracyclines. Front Cardiovasc med 7:26

pubmed: 32258060 pmcid: 7093379 doi: 10.3389/fcvm.2020.00026

Cardoso CV, de Barros MP, Bachi ALL et al (2020) Chemobrain in rats: behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration. Behav Brain Res 378:112233

pubmed: 31521736 doi: 10.1016/j.bbr.2019.112233

Cavalier AN, Clayton ZS, Hutton DA et al (2021) Accelerated aging of the brain transcriptome by the common chemotherapeutic doxorubicin. Exp Gerontol 152:111451

pubmed: 34147619 pmcid: 8319121 doi: 10.1016/j.exger.2021.111451

Chahine N, Nader M, Duca L, Martiny L, Chahine R (2016) Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro. Drug Chem Toxicol 39(1):87–96

pubmed: 25885550 doi: 10.3109/01480545.2015.1036281

Chegaev K, Riganti C, Rolando B, Lazzarato L et al (2013) Doxorubicin-antioxidant co-drugs. Bioorg Med Chem Lett 23(19):5307–5310

pubmed: 23973213 doi: 10.1016/j.bmcl.2013.07.070

Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H (2009) Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug resistant cancer cells. Small 5(23):2673

pubmed: 19780069 pmcid: 2833276 doi: 10.1002/smll.200900621

Cheng CF, Juan SH, Chen JJ, Chao YC, Chen HH et al (2008) Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis. Apoptosis 13:883–894

pubmed: 18483861 doi: 10.1007/s10495-008-0214-9

Cheng X, Fan K, Wang L, Ying X et al (2020) TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer. Cell Death Dis 11(2):92

pubmed: 32024821 pmcid: 7002446 doi: 10.1038/s41419-020-2272-z

Chhikara BS, Mandal D, Parang K (2012) Synthesis, anticancer activities, and cellular uptake studies of lipophilic derivatives of doxorubicin succinate. J Med Chem 55(4):1500–1510

pubmed: 22276998 doi: 10.1021/jm201653u

Chiorazzi A, Semperboni S, Marmiroli P (2015) Current view in platinum drug mechanisms of peripheral neurotoxicity. Toxics 3(3):304–321

pubmed: 29051466 pmcid: 5606682 doi: 10.3390/toxics3030304

Choi JS, Doh KO, Kim BK, Seu YB (2017) Synthesis of cholesteryl doxorubicin and its anti-cancer activity. Bioorg Med Chem Lett 27(4):723–728

pubmed: 28129977 doi: 10.1016/j.bmcl.2017.01.048

Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149(6):1192–1205

pubmed: 22682243 doi: 10.1016/j.cell.2012.05.012

Cordier PY, Nau A, Ciccolini J, Oliver M, Mercier C et al (2011) 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases. Cancer Chemother Pharmacol 68:823–826

pubmed: 21553285 doi: 10.1007/s00280-011-1666-0

Da Costa R, Passos GF, Quintão NL, Fernandes ES, Maia JRL et al (2020) Taxane-induced neurotoxicity: pathophysiology and therapeutic perspectives. Br J Pharmacol 177(14):3127–3146

pubmed: 32352155 pmcid: 7312267 doi: 10.1111/bph.15086

de Oliveira BE, Amorim OHJ, Lima LL, Rezende RA, Mestnik NC, Bagatin E, Leonardi GR (2021) 5-Fluorouracil, innovative drug delivery systems to enhance bioavailability for topical use. J Drug Deliv Sci Technol 61:102155

doi: 10.1016/j.jddst.2020.102155

Demaria M, O’Leary MN, Chang J, Shao L et al (2017) Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov 7(2):165–176

pubmed: 27979832 doi: 10.1158/2159-8290.CD-16-0241

Di X, Shiu RP, Newsham IF, Gewirtz DA (2009) Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol 77(7):1139–1150

pubmed: 19185564 doi: 10.1016/j.bcp.2008.12.016

Dias-Carvalho A, Ferreira M, Ferreira R, Bastos MDL, Sá SI et al (2022) Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events. Arch Toxicol 1–68

Dias-Carvalho A, Ferreira M, Reis-Mendes A, Ferreira R et al (2024) Doxorubicin-induced neurotoxicity differently affects the hippocampal formation subregions in adult mice. Heliyon

Dodig S, Čepelak I, Pavić I (2019) Hallmarks of senescence and aging. Biochemia Med 29(3):483–497

doi: 10.11613/BM.2019.030501

Dokshokova L, Franzoso M, Di Bona A, Moro N, Sanchez Alonso JL et al (2022) Nerve growth factor transfer from cardiomyocytes to innervating sympathetic neurons activates TrkA receptors at the neuro-cardiac junction. J Physiol 600(12):2853–2875

pubmed: 35413134 doi: 10.1113/JP282828

Du J, Zhang A, Li J, Liu X, Wu S et al (2021) Doxorubicin-induced cognitive impairment: the mechanistic insights. Front Oncol 11:673340

pubmed: 34055643 pmcid: 8158153 doi: 10.3389/fonc.2021.673340

Duan J, Mansour HM, Zhang Y et al (2012) Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly (butyl cyanoacrylate) nanoparticles. Int J Pharm 426(1–2):193–201

pubmed: 22274587 doi: 10.1016/j.ijpharm.2012.01.020

Eide S, Feng ZP (2020) Doxorubicin chemotherapy-induced chemo-brain: Meta-analysis. Eur J Pharmacol 881:173078

pubmed: 32505665 doi: 10.1016/j.ejphar.2020.173078

El-Agamy SE, Abdel-Aziz AK, Wahdan S, Esmat A, Azab SS (2018) Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries. Molec Neurobiol 55:5727–5740

doi: 10.1007/s12035-017-0797-7

Erdem-Guzel E, Kaya Tektemur N, Tektemur A (2021) Alpha-lipoic acid may ameliorate testicular damage by targeting dox‐induced altered antioxidant parameters, mitofusin‐2 and apoptotic gene expression. Andrologia 53(3), e13990

Eslami M, Memarsadeghi O, Davarpanah A, Arti A, Nayernia K, Behnam B (2024) Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review. Biomedicines 12(1):183

pubmed: 38255288 pmcid: 10812960 doi: 10.3390/biomedicines12010183

Esnaashari SS, Muhammadnejad S, Amanpour S, Amani A (2020) A combinational approach towards treatment of breast cancer: an analysis of noscapine-loaded polymeric nanoparticles and doxorubicin. AAPS PharmSciTech 21:1–12

doi: 10.1208/s12249-020-01710-3

Fernandez HR, Varma A, Flowers SA, Rebeck GW (2020) Cancer chemotherapy related cognitive impairment and the impact of the Alzheimer’s disease risk factor APOE. Cancers 12(12):3842

pubmed: 33352780 pmcid: 7766535 doi: 10.3390/cancers12123842

Field TM, Shin M, Stucky CS, Loomis J, Johnson MA (2018) Electrochemical measurement of dopamine release and uptake in zebrafish following treatment with carboplatin. ChemPhysChem 19(10):1192–1196

pubmed: 29573086 pmcid: 6013284 doi: 10.1002/cphc.201701357

Gaillard PJ, Appeldoorn CC, Dorland R, Van Kregten J, Manca F et al (2014) Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101). PLoS ONE 9(1), e82331

Găman AM, Egbuna C, Găman MA (2020) Natural bioactive lead compounds effective against haematological malignancies. Phytochemicals as lead Compd new drug Discovery, 95–115

Garthe A, Kempermann G (2013) An old test for new neurons: refining the Morris water maze to study the functional relevance of adult hippocampal neurogenesis. Front Neurosci 7:63

pubmed: 23653589 pmcid: 3642504 doi: 10.3389/fnins.2013.00063

Gavas S, Quazi S, Karpiński TM (2021) Nanoparticles for cancer therapy: current progress and challenges. Nanoscale res lett 16(1):173

pubmed: 34866166 pmcid: 8645667 doi: 10.1186/s11671-021-03628-6

Ghosh P, Tiwari H, Lakkakula J, Roy A, Emran TB et al (2022) A decade’s worth of impact: dox loaded liposomes in anticancer activity. Mat Today Adv 16:100313

doi: 10.1016/j.mtadv.2022.100313

Global Burden of Disease Cancer Collaboration (2019) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 5(12):1749–1768

pmcid: 6777271 doi: 10.1001/jamaoncol.2019.2996

Go RS, Adjei AA (1999) Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17(1):409–409

pubmed: 10458260 doi: 10.1200/JCO.1999.17.1.409

Gong C, Tian J, Wang Z, Gao Y, Wu X et al (2019) Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotech 17(1):1–18

doi: 10.1186/s12951-019-0526-7

Guan M, Su L, Yuan YC, Li H, Chow WA (2015) Nelfinavir and nelfinavir analogs block site-2 protease cleavage to inhibit castration-resistant prostate cancer. Sci Rep 5(1):9698

pubmed: 25880275 pmcid: 4816264 doi: 10.1038/srep09698

Gulati R, Nandi D, Sarkar K, Venkataraman P, Ramkumar KM et al (2022) Exosomes as theranostic targets: implications for the clinical prognosis of aggressive cancers. Front Molec Biosci 9:890768

doi: 10.3389/fmolb.2022.890768

Gutmann DH (2019) Clearing the fog surrounding chemobrain. Cell 176(1):2–4

pubmed: 30633904 doi: 10.1016/j.cell.2018.12.027

Hao WU, Xu JS, Li YH, Wu XH, Wei HU et al (2022) Tetrahedral DNA nanostructure-modified gold nanorod-based Anticancer nanomaterials for Combined Photothermal Therapy and Chemotherapy. Biomed Environ Sci 35(12):1115–1125

Hashkes PJ, Becker ML, Cabral DA, Laxer RM, Paller AS et al (2014) Methotrexate: new uses for an old drug. J Pediatr 164(2):231–236

pubmed: 24286573 doi: 10.1016/j.jpeds.2013.10.029

Hayslip J, Dressler EV, Weiss H, Taylor TJ, Chambers M et al (2015) Plasma TNF-α and soluble TNF receptor levels after doxorubicin with or without co-administration of mesna—a randomized, cross-over clinical study. PLoS ONE, 10(4), e0124988

Heier MS, Dornish JM (1989) Effect of the fluoropyrimidines 5-fluorouracil and doxifluridine on cellular uptake of thiamin. Anticancer Res 9(4):1073–1077

pubmed: 2530931

Hendriks BS, Reynolds JG, Klinz SG, Geretti E, Lee H et al (2012) Multiscale kinetic modeling of liposomal doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors. CPT: Pharmacometrics Syst Pharmacol 1(11):1–11

Henneghan A, Haley AP, Kesler S (2020) Exploring relationships among peripheral amyloid beta, tau, cytokines, cognitive function, and psychosomatic symptoms in breast cancer survivors. Biol Res Nurs 22(1):126–138

pubmed: 31707784 doi: 10.1177/1099800419887230

Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28(6):436–453

pubmed: 29477613 doi: 10.1016/j.tcb.2018.02.001

Herrmann J (2020) Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol 17(8):474–502

pubmed: 32231332 pmcid: 8782611 doi: 10.1038/s41569-020-0348-1

Holmes D (2013) Trying to unravel the mysteries of chemobrain. Lancet Neurol 12(6):533–534

pubmed: 23602780 doi: 10.1016/S1474-4422(13)70087-5

Hsu WH, Ku CL, Lai YR, Wang SSS, Chou SH et al (2023) Developing targeted drug delivery carriers for breast cancer using glutathione-sensitive doxorubicin-coupled glycated bovine serum albumin nanoparticles. Int J Biol Macromolec 249:126114

doi: 10.1016/j.ijbiomac.2023.126114

Hu X, Zhang H (2019) Doxorubicin-induced cancer cell senescence shows a time delay effect and is inhibited by epithelial-mesenchymal transition (EMT). Med Sci Monitor: Int Med J Experimental Clin Res 25:3617

doi: 10.12659/MSM.914295

Hu M, Yingyu Z, Zhang M, Wang Q, Cheng W, Hou L et al (2024) Functionalizing tetrahedral framework nucleic acids-based nanostructures for tumor in situ imaging and treatment. Colloids Surf B, 113982

Huang X, El-Sayed IH, Qian W, El-Sayed MA (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 128(6):2115–2120

pubmed: 16464114 doi: 10.1021/ja057254a

Huang Q, Aluise CD, Joshi G, Sultana R, St. Clair DK et al (2010) Potential in vivo amelioration by N-acetyl‐L‐cysteine of oxidative stress in brain in human double mutant APP/PS‐1 knock‐in mice: toward therapeutic modulation of mild cognitive impairment. J Neurosci res 88(12):2618–2629

pubmed: 20648652 doi: 10.1002/jnr.22422

Ibrahim SS, Elseoud OGA, Mohamedy MH, Amer MM, Mohamed YY et al (2021) Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways. Neuropharmacol 197:108738

doi: 10.1016/j.neuropharm.2021.108738

Ibrahim Fouad G (2020) Combination of omega 3 and coenzyme Q10 exerts neuroprotective potential against hypercholesterolemia-induced Alzheimer’s-like disease in rats. Neurochem Res 45(5):1142–1155

pubmed: 32124160 doi: 10.1007/s11064-020-02996-2

Ibrahim Fouad GI, Ahmed KA (2021a) Neuroprotective potential of berberine against doxorubicin-induced toxicity in rat’s brain. Neurochem Res 46(12), 3247–3263

pubmed: 34403065 doi: 10.1007/s11064-021-03428-5

Ibrahim Fouad GI, Ahmed KA (2021b) The protective impact of berberine against doxorubicin-induced nephrotoxicity in rats. Tissue Cell 73, 101612

pubmed: 34371291 doi: 10.1016/j.tice.2021.101612

Ibrahim Fouad GI, Ahmed KA (2022) Curcumin ameliorates doxorubicin-induced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS, NF-κB, and TNF-α in rats. Cardiovasc Toxicol 22(2):152–166

pubmed: 34837640 doi: 10.1007/s12012-021-09710-w

Ibrahim Fouad G, El-Sayed SA, Mabrouk M et al (2022) Neuroprotective potential of intranasally delivered sulforaphane-loaded iron oxide nanoparticles against cisplatin-induced neurotoxicity. Neurotox Res 40(5):1479–1498

pubmed: 35969308 pmcid: 9515146 doi: 10.1007/s12640-022-00555-x

Illias AM, Gist AC, Zhang H, Kosturakis AK, Dougherty PM (2018) Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity. Pain 159(7):1308–1316

pubmed: 29554018 pmcid: 6008166 doi: 10.1097/j.pain.0000000000001212

Im EJ, Lee CH, Moon PG, Rangaswamy GG et al (2019) Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor A. Nat Commun 10(1):1387

pubmed: 30918259 pmcid: 6437193 doi: 10.1038/s41467-019-09387-4

Imosemi IO, Owumi SE, Arunsi UO (2022) Biochemical and histological alterations of doxorubicin-induced neurotoxicity in rats: protective role of luteolin. J Biochem Molec Toxicol 36(3), e22962

Itoo AM, Paul M, Ghosh B, BiswasS (2023) Polymeric graphene oxide nanoparticles loaded with doxorubicin for combined photothermal and chemotherapy in triple negative breast cancer. Biomat Adv 153:213550

Iwasaki H, Inoue H, Mitsuke Y, Badran A, Ikegaya S, Ueda T (2002) Doxycycline induces apoptosis by way of caspase-3 activation with inhibition of matrix metalloproteinase in human T-lymphoblastic leukemia CCRF-CEM cells. J Lab Clin Med 140(6):382–386

pubmed: 12486404 doi: 10.1067/mlc.2002.129308

Jia L, Piña-Crespo J, Li Y (2019) Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease. Molec Brain 12:1–11

doi: 10.1186/s13041-019-0525-5

Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes HS et al (2020) Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Annals Oncol 31(10):1306–1319

doi: 10.1016/j.annonc.2020.07.003

Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM et al (2010) Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neurosci 166(3):796–807

doi: 10.1016/j.neuroscience.2010.01.021

Kamińska K, Cudnoch-Jędrzejewska AA (2023) Review on the neurotoxic effects of Doxorubicin. Neurotox Res 1–15

Kaplan SV, Limbocker RA, Gehringer RC, Divis JL et al (2016) Impaired brain dopamine and serotonin release and uptake in Wistar rats following treatment with carboplatin. ACS Chem Neurosci 7(6):689–699

pubmed: 27145395 doi: 10.1021/acschemneuro.5b00029

Karabicici M, Alptekin S, Fırtına Karagonlar Z, Erdal E (2021) Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM–/CD133 – nonstem cell population in hepatocellular carcinoma cell line, HuH‐7. Mol Oncol 15(8):2185–2202

pubmed: 33524223 pmcid: 8334288 doi: 10.1002/1878-0261.12916

Kciuk M, Gielecińska A, Mujwar S, Kołat D et al (2023) Doxorubicin—an agent with multiple mechanisms of anticancer activity. Cells 12(4):659

pubmed: 36831326 pmcid: 9954613 doi: 10.3390/cells12040659

Keeney JT, Ren X, Warrier G, Noel T, Powell DK et al (2018) Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (chemobrain). Oncotarget 9(54):30324

pubmed: 30100992 pmcid: 6084398 doi: 10.18632/oncotarget.25718

Khadrawy YA, Hosny EN, Mohammed HS (2021) Protective effect of nanocurcumin against neurotoxicity induced by doxorubicin in rat’s brain. Neurotoxicology 85:1–9

pubmed: 33882267 doi: 10.1016/j.neuro.2021.04.003

Kim KR, Kim DR, Lee T, Yhee JY, Kim BS, Kwon IC, Ahn DR (2013) Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells. Chem Commun 49(20):2010–2012

doi: 10.1039/c3cc38693g

Kinra M, Ranadive N, Gourishetti K, Nayak PG, Jagdale RN et al (2021) Neuroprotective effect of Mulmina™ against chemotherapyinduced cognitive decline in normal mice Erratum in/10.3892/br. 2021.1433. Biomed rep 14(1):1–1

pubmed: 33235718 doi: 10.3892/br.2020.1377

Kirtonia A, Gala K, Fernandes SG, Pandya G, Pandey AK, Sethi G et al (2021) Repurposing of drugs: an attractive pharmacological strategy for cancer therapeutics. Seminars in cancer biology, vol 68. Academic, pp 258–278

Kuzu M, Kandemir FM, Yildirim S, Kucukler S, Caglayan C et al (2018) Morin attenuates doxorubicin-induced heart and brain damage by reducing oxidative stress, inflammation and apoptosis. Biomed Pharmaco 106:443–453

doi: 10.1016/j.biopha.2018.06.161

Laudisi F, Marônek M, Di Grazia A, Monteleone G, Stolfi C (2020) Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system. Int J Mol Sci 21(14):4957

pubmed: 32668817 pmcid: 7404055 doi: 10.3390/ijms21144957

Lauretti E, Dincer O, Praticò D (2020) Glycogen synthase kinase-3 signaling in Alzheimer’s disease. BBA-Molecular Cell Res 1867(5):118664

Lee YJ, Lee C (2018) Porcine deltacoronavirus induces caspase-dependent apoptosis through activation of the cytochrome c-mediated intrinsic mitochondrial pathway. Virus res 253:112–123

pubmed: 29940190 doi: 10.1016/j.virusres.2018.06.008

Leung WS, Kuo WW, Ju DT, Wang TD, Chen WST et al (2020) Protective effects of diallyl trisulfide (DATS) against doxorubicin-induced inflammation and oxidative stress in the brain of rats. Free Radical Biol Med 160:141–148

doi: 10.1016/j.freeradbiomed.2020.07.018

Levine PM, Silberfarb PM, Lipowski ZJ (1978) Mental disorders in cancer patients. A study of 100 psychiatric referrals. Cancer 42(3):1385–1391

pubmed: 698920 doi: 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0

Li X (2023) Doxorubicin-mediated cardiac dysfunction: revisiting molecular interactions, pharmacological compounds and (nano) theranostic platforms. Environ Res 116504

Li L, Leung PS (2014) Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer. Int J Biochem cell biol 53:224–236

pubmed: 24875648 doi: 10.1016/j.biocel.2014.05.021

Li J, Pei H, Zhu B, Liang L, Wei M, He Y et al (2011) Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano 5(11):8783–8789

pubmed: 21988181 doi: 10.1021/nn202774x

Li F, Huang J, Ji D, Meng Q, Wang C et al (2017) Azithromycin effectively inhibits tumor angiogenesis by suppressing vascular endothelial growth factor receptor 2mediated signaling pathways in lung cancer. Oncol Lett 14(1):89–96

pubmed: 28693139 pmcid: 5494938 doi: 10.3892/ol.2017.6103

Li J, Zhang C, Gong S, Li X, Yu M et al (2019) A nanoscale photothermal agent based on a metal-organic coordination polymer as a drug-loading framework for effective combination therapy. Acta Biomater 94:435–446

pubmed: 31216493 doi: 10.1016/j.actbio.2019.06.014

Li Z, Ye Z, Ma J, Gu Q, Teng J et al (2021) MicroRNA-133b alleviates doxorubicininduced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2. Int J Molec Med 48(1):1–11

doi: 10.3892/ijmm.2021.4958

Liang CH, Ye WL, Zhu CL et al (2014) Synthesis of doxorubicin α-linolenic acid conjugate and evaluation of its antitumor activity. Mol Pharm 11(5):1378–1390

pubmed: 24720787 doi: 10.1021/mp4004139

Liang L, Tu Y, Lu J, Wang P, Guo Z et al (2019) Dkk1 exacerbates doxorubicin-induced cardiotoxicity by inhibiting the Wnt/β-catenin signaling pathway. J Cell Sci 132(10):jcs228478

pubmed: 31028181 doi: 10.1242/jcs.228478

Liao Z, Nan G, Yan Z, Zeng L, Deng Y et al (2015) The anthelmintic drug niclosamide inhibits the proliferative activity of human osteosarcoma cells by targeting multiple signal pathways. Curr Cancer Drug Targets 15(8):726–738

pubmed: 26118906 doi: 10.2174/1568009615666150629132157

Liao D, Zhang C, Liu N, Cao L, Wang C et al (2020) Involvement of neurotrophic signaling in doxorubicininduced cardiotoxicity. Exp Therapeutic Med 19(2):1129–1135

Liao D, Shangguan D, Wu Y, Chen Y, Liu N et al (2023) Curcumin protects against doxorubicin induced oxidative stress by regulating the Keap1-Nrf2-ARE and autophagy signaling pathways. Psychopharmacology 240(5):1179–1190

pubmed: 36949340 pmcid: 10102057 doi: 10.1007/s00213-023-06357-z

Lin SR, Chang CH, Hsu CF, Tsai MJ et al (2020) Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol 177(6):1409–1423

pubmed: 31368509 doi: 10.1111/bph.14816

Liu RY, Zhang Y, Coughlin BL, Cleary LJ, Byrne JH (2014) Doxorubicin attenuates serotonin-induced long-term synaptic facilitation by phosphorylation of p38 mitogen-activated protein kinase. J Neurosci 34(40):13289–13300

pubmed: 25274809 pmcid: 4180468 doi: 10.1523/JNEUROSCI.0538-14.2014

Liyanage PY, Hettiarachchi SD, Zhou Y, Ouhtit A, Seven ES et al (2019) Nanoparticle-mediated targeted drug delivery for breast cancer treatment. BBA-Reviews Cancer 1871(2):419–433

Loghin ME, Kleiman A (2020) Medication-induced neurotoxicity in critically ill cancer patients. Oncologic Crit Care 319–334

Lomeli N, Di K, Czerniawski J, Guzowski JF, Bota DA (2017) Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats. Free Radical Biol Med 102:274–286

doi: 10.1016/j.freeradbiomed.2016.11.046

López-Gómez L, Abalo R, Vera G (2023) Central Neurotoxicity of Chemotherapy. Handb Cancer Immunol 1–27

Lucato LT, McKinney AM, Short J, Teksam M, Truwit CL (2006) Reversible findings of restricted diffusion in 5-flourouracil neurotoxicity. Australasian Radio 50(4):364–368

doi: 10.1111/j.1440-1673.2006.01602.x

Lyros E, Walter S, Keller I, Papanagiotou P, Fassbender K (2014) Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology. Neurotoxicol 42:8–11

doi: 10.1016/j.neuro.2014.02.010

Ma GL, Lin WF (2023) Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy. Military Med Res 10(1):1–16

doi: 10.1186/s40779-023-00455-x

Mabrouk M, Ibrahim Fouad G et al (2021) Hepatotoxic and neurotoxic potential of iron oxide nanoparticles in Wistar rats: a biochemical and ultrastructural study. Biol Trace Elem Res 1–28

Magge RS, DeAngelis LM (2015) The double-edged sword: neurotoxicity of chemotherapy. Blood rev 29(2):93–100

pubmed: 25445718 doi: 10.1016/j.blre.2014.09.012

Mahmoodazdeh A, Shafiee SM, Sisakht M, Khoshdel Z, Takhshid MA (2020) Adrenomedullin protects rat dorsal root ganglion neurons against doxorubicin-induced toxicity by ameliorating oxidative stress. Iran J Basic Med Scienc 23(9):1197

Manchon JFM, Uzor NE, Kesler SR, Wefel JS, Townley DM et al (2016a) TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging, 8(12), 3507

doi: 10.18632/aging.101144

Manchon JFM, Dabaghian Y, Uzor NE, Kesler SR, Wefel JS et al (2016b) Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neurons. Sci rep 6(1), 25705

pubmed: 27168474 pmcid: 4863375 doi: 10.1038/srep25705

Mastria EM, Cai LY, Kan MJ, Li X et al (2018) Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity. J Controlled Release 269:364–373

doi: 10.1016/j.jconrel.2017.11.021

Mattioli R, Ilari A, Colotti B, Mosca L, Fazi F, Colotti G (2023) Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Aspects Med 93:101205

pubmed: 37515939 doi: 10.1016/j.mam.2023.101205

Mayer DK, Nasso SF, Earp JA (2017) Defining cancer survivors, their needs, and perspectives on survivorship health care in the USA. Lancet Oncol 18(1):e11–e18

pubmed: 28049573 doi: 10.1016/S1470-2045(16)30573-3

McQuade RM, Al Thaalibi M, Nurgali K (2020) Impact of chemotherapy-induced enteric nervous system toxicity on gastrointestinal mucositis. Curr Opin Support Palliat Care 14(3):293–300

pubmed: 32769620 doi: 10.1097/SPC.0000000000000515

McWhinney SR, Goldberg RM, McLeod HL (2009) Platinum neurotoxicity pharmacogenetics. Molec cancer Ther 8(1):10–16

doi: 10.1158/1535-7163.MCT-08-0840

Merino M, Lozano T, Casares N, Lana H, Troconiz IF et al (2021) Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model. J Nanobiotechnol 19:1–15

doi: 10.1186/s12951-021-00846-z

Miltenburg NC, Boogerd W (2014) Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat rev 40(7):872–882

pubmed: 24830939 doi: 10.1016/j.ctrv.2014.04.004

Miranda M, Morici JF, Zanoni MB, Bekinschtein P (2019) Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 363

Misra R, Sahoo SK (2011) Coformulation of doxorubicin and curcumin in poly (D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Mol Pharm 8(3):852–866

pubmed: 21480667 doi: 10.1021/mp100455h

Mohamad HE, Abo-Elmatty DM, Wahba NS, Shaheen MA, Sakr RT et al (2022) Infliximab and/or MESNA alleviate doxorubicin-induced Alzheimer’s disease-like pathology in rats: a new insight into TNF-α/Wnt/β-catenin signaling pathway. Life Sci 301:120613

pubmed: 35523286 doi: 10.1016/j.lfs.2022.120613

Mohanty S, Panda S, Devadharshini U, Paul S (2023) Proteins and their functionalization for finding therapeutic avenues in cancer: current status and future prospective. BBA-Reviews on Cancer, p 188862

Mohi-Ud-Din R, Chawla A, Sharma P, Mir PA, Potoo FH, Reiner Ž, Reiner I, Ateşşahin DA, Sharifi-Rad J, Mir RH, Calina D (2023) Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects. Eur J Med Res 28(1):345. https://doi.org/10.1186/s40001-023-01275-4

doi: 10.1186/s40001-023-01275-4 pubmed: 37710280 pmcid: 10500791

Monisha J, Jaiswal A, Banik K, Choudhary H, Singh AK, Bordoloi D, Kunnumakkara AB (2018) Cancer cell chemoresistance: a prime obstacle in cancer therapy. In Cancer cell chemoresistance and chemosensitization (pp. 15–49)

Moretti RL, Dias EN, Kiel SG, Augusto MCM, Rodrigues PS et al (2021) Behavioral and morphological effects of resveratrol and curcumin in rats submitted to doxorubicin-induced cognitive impairment. Res Vet Sci 140:242–250

pubmed: 34536813 doi: 10.1016/j.rvsc.2021.09.009

Moro N, Dokshokova L, Perumal VI, Prando V, Cnudde SJA et al (2022) Neurotoxic effect of doxorubicin treatment on cardiac sympathetic neurons. Int J Molec Sci 23(19):11098

doi: 10.3390/ijms231911098

Morran DC, Wu J, Jamieson NB, Mrowinska A et al (2014) Targeting mTOR dependency in pancreatic cancer. Gut 63(9):1481–1489

pubmed: 24717934 doi: 10.1136/gutjnl-2013-306202

Motawi TM, Sadik NA, Fahim SA, Shouman SA (2015) Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells. Chemico-Biol Interact 233:147–156

doi: 10.1016/j.cbi.2015.03.028

Moudi M, Go R, Yien CYS, Nazre M (2013) Vinca alkaloids. Int J Prev Med 4(11):1231

pubmed: 24404355 pmcid: 3883245

Mu L, Wang J, Cao B, Jelfs B, Chan RH et al (2015) Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex. Mol Brain 8:1–15

doi: 10.1186/s13041-015-0125-y

Mustafa S, Walker A, Bennett G, Wigmore PM (2008) 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 28(2):323–330

pubmed: 18702703 doi: 10.1111/j.1460-9568.2008.06325.x

Naeem A, Hu P, Yang M, Zhang J, Liu Y, Zhu W, Zheng Q (2022) Natural products as anticancer agents: current status and future perspectives. Molecules 27(23):8367

pubmed: 36500466 pmcid: 9737905 doi: 10.3390/molecules27238367

Neitzel C, Seiwert N, Göder A et al (2019) Lipoic acid synergizes with antineoplastic drugs in colorectal cancer by targeting p53 for proteasomal degradation. Cells 8(8):794

pubmed: 31366086 pmcid: 6721634 doi: 10.3390/cells8080794

Nelson DL, Cox MM (2013) Bioenergetics and metabolism lehninger principles of biochemistry

Newton HB (2012) Neurological complications of chemotherapy to the central nervous system. Handb Clin Neurol 105:903–916

pubmed: 22230541 doi: 10.1016/B978-0-444-53502-3.00031-8

Nguyen LD, Ehrlich BE (2020) Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Molec med 12(6), e12075

Norouzi M, Yathindranath V, Thliveris JA et al (2020) Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci Rep 10(1):11292

pubmed: 32647151 pmcid: 7347880 doi: 10.1038/s41598-020-68017-y

Okuyucu CE, Kalaycioglu GD, Kacaroglu D, Ozden AK, Aydogan N (2023) Trojan-like doxorubicin and gold nanoparticle entrapped smart nanostructured lipid carriers for breast cancer synergistic chemo/photothermal therapy. Colloids Surf a 131763

Ongnok B, Chattipakorn V, Chattipakorn SC (2020) Doxorubicin and cisplatin induced cognitive impairment: the possible mechanisms and interventions. Exp Neurol 324:113118

pubmed: 31756316 doi: 10.1016/j.expneurol.2019.113118

Ongnok B, Khuanjing T, Chunchai T, Pantiya P, Kerdphoo S et al (2021) Donepezil protects against doxorubicin-induced chemobrain in rats via attenuation of inflammation and oxidative stress without interfering with doxorubicin efficacy. Neurotherapeut 18:2107–2125

doi: 10.1007/s13311-021-01092-9

Ongnok B, Maneechote C, Chunchai T, Pantiya P, Arunsak B et al (2022) Modulation of mitochondrial dynamics rescues cognitive function in rats with ‘doxorubicin-induced chemobrain via mitigation of mitochondrial dysfunction and neuroinflammation. FEBS J 289(20):6435–6455

pubmed: 35514149 doi: 10.1111/febs.16474

Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N (2004) Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med 143(4):207–216

pubmed: 15085079 doi: 10.1016/j.lab.2003.12.012

Oo TT, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2022) Emerging roles of toll-like receptor 4 in chemotherapy-induced neurotoxicity. Neurotoxicol 93:112–127

doi: 10.1016/j.neuro.2022.09.006

Ortí-Casañ N, Wu Y, Naudé PJ, De Deyn PP, Zuhorn IS et al (2019) Targeting TNFR2 as a novel therapeutic strategy for Alzheimer’s disease. Front Neurosci 13:49

pubmed: 30778285 pmcid: 6369349 doi: 10.3389/fnins.2019.00049

Owoeye O, Adedara IA, Farombi EO (2018) Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomed Pharmaco 102:375–384

doi: 10.1016/j.biopha.2018.03.051

Owumi SE, Lewu DO, Arunsi UO, Oyelere AK (2021) Luteolin attenuates doxorubicin-induced derangements of liver and kidney by reducing oxidative and inflammatory stress to suppress apoptosis. Hum Exp Toxicol 40(10):1656–1672

pubmed: 33827303 doi: 10.1177/09603271211006171

Oxman TE, Silberfarb PM (1980) Serial cognitive testing in cancer patients receiving chemotherapy. Am j Psychiatry 137(10):1263–1265

pubmed: 7416282 doi: 10.1176/ajp.137.10.1263

Pal S, Ahir M, Sil PC (2012) Doxorubicin-induced neurotoxicity is attenuated by a 43-kD protein from the leaves of Cajanus indicus L. via NF-κB and mitochondria dependent pathways. Free Radical res 46(6):785–798

doi: 10.3109/10715762.2012.678841

Park HS, Kim CJ, Kwak HB, No MH et al (2018) Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain. Neuropharmaco 133:451–461

doi: 10.1016/j.neuropharm.2018.02.013

Parsa MB, Tafvizi F, Chaleshi V, Ebadi M (2023) Preparation, characterization, and co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer activities. Heliyon 9(10), e20657

Pellacani C, Eleftheriou G (2020) Neurotoxicity of antineoplastic drugs: mechanisms, susceptibility, and neuroprotective strategies. Adv Medic sci 65(2):265–285

doi: 10.1016/j.advms.2020.04.001

Peter S, Alven S, Maseko RB, Aderibigbe BA (2022) Doxorubicin-based hybrid compounds as potential anticancer agents: a review. Molecules 27(14):4478

pubmed: 35889350 pmcid: 9318127 doi: 10.3390/molecules27144478

Pore N, Gupta AK, Cerniglia GJ, Jiang Z et al (2006) Nelfinavir down-regulates hypoxia-inducible factor 1α and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res 66(18):9252–9259

pubmed: 16982770 doi: 10.1158/0008-5472.CAN-06-1239

Pramanik D, Campbell NR, Das S et al (2012) A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget 3(6):640

pubmed: 22791660 pmcid: 3442295 doi: 10.18632/oncotarget.543

Prša P, Karademir B, Biçim G, Mahmoud H, Dahan I et al (2020) The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics. Biochemi Pharmacol 173:113551

doi: 10.1016/j.bcp.2019.06.007

Qian J, Xia M, Liu W, Li L et al (2019) Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Eur J Pharmacol 852:231–243

pubmed: 30959046 doi: 10.1016/j.ejphar.2019.04.002

Ramalingayya GV, Cheruku SP, Nayak PG, Kishore A, Shenoy R et al (2017) Rutin protects against neuronal damage in vitro and ameliorates doxorubicin-induced memory deficits in vivo in Wistar rats. Drug design, development and therapy, 1011–1026

Rehman SU, Ali T, Alam SI, Ullah R, Zeb A et al (2019) Ferulic acid rescues LPS-induced neurotoxicity via modulation of the TLR4 receptor in the mouse hippocampus. Molec Neurobiol 56:2774–2790

doi: 10.1007/s12035-018-1280-9

Ren X, Clair DKS, Butterfield DA (2017) Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol res 117:267–273

pubmed: 28063894 doi: 10.1016/j.phrs.2017.01.001

Ren X, Keeney JT, Miriyala S, Noel T, Powell DK et al (2019) The triangle of death of neurons: oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (chemobrain) involving TNF-α. Free Radical Biol Med 134:1–8

doi: 10.1016/j.freeradbiomed.2018.12.029

Renu K, Pureti LP, Vellingiri B, Valsala Gopalakrishnan A (2022) Toxic effects and molecular mechanism of doxorubicin on different organs–an update. Toxin Rev 41(2):650–674

doi: 10.1080/15569543.2021.1912099

Rizk HA, Masoud MA, Maher OW (2017) Prophylactic effects of ellagic acid and rosmarinic acid on doxorubicin-induced neurotoxicity in rats. J Biochem Molec Toxicol 31(12), e21977

Rollins N, Winick N, Bash R, Booth T (2004) Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. Am J Neuroradiol 25(10):1688–1695

pubmed: 15569732 pmcid: 8148738

Rommasi F, Esfandiari N (2021) Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Res Lett 16(1):95

pubmed: 34032937 pmcid: 8149564 doi: 10.1186/s11671-021-03553-8

Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H et al (2012) Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 30(14):1692–1698

pubmed: 22473169 doi: 10.1200/JCO.2011.40.4905

Rudin CM, Brahmer JR, Juergens RA, Hann CL, Ettinger DS et al (2013) Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non–small-cell lung cancer. J Thorac Oncol 8(5):619–623

pubmed: 23546045 pmcid: 3636564 doi: 10.1097/JTO.0b013e31828c3950

Rummel NG, Chaiswing L, Bondada SS, Clair DK, Butterfield DA (2021) Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα. Cell Molec Life Sci 78(19–20):6533–6540

pubmed: 34424346 pmcid: 10561769 doi: 10.1007/s00018-021-03925-4

Rutckeviski R, Corso CR, Román-Ochoa Y, Cipriani TR, Centa A, Smiderle FR (2022) Agaricus Bisporus β-(1→ 6)-d-glucan induces M1 phenotype on macrophages and increases sensitivity to doxorubicin of triple negative breast cancer cells. Carbohydr Polym 278:118917

pubmed: 34973736 doi: 10.1016/j.carbpol.2021.118917

Saharkhiz S, Zarepour A, Zarrabi A (2023) A new theranostic pH-responsive niosome formulation for doxorubicin delivery and bio-imaging against breast cancer. Int J Pharm 637:122845

pubmed: 36958608 doi: 10.1016/j.ijpharm.2023.122845

Sahu K, Langeh U, Singh C, SinghA (2021) Crosstalk between anticancer drugs and mitochondrial functions. Curr Res Pharmaco Drug Discov 2:100047

Sardi I, la Marca G, Cardellicchio S, Giunti L, Malvagia S et al (2013) Pharmacological modulation of blood-brain barrier increases permeability of doxorubicin into the rat brain. Am J cancer res 3(4):424

pubmed: 23977451 pmcid: 3744021

Sato A, Asano T, Ito K, Asano T (2012) Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells. Urology 79(4):966–e13

doi: 10.1016/j.urology.2011.11.033

Schoch S, Gajewski S, Rothfuß J, Hartwig A, Köberle B (2020) Comparative study of the mode of action of clinically approved platinum-based chemotherapeutics. Int J Mol Sci 21(18):6928

pubmed: 32967255 pmcid: 7555145 doi: 10.3390/ijms21186928

Seaberg EC, Wiley D, Martínez-Maza O, Chmiel JS, Kingsley L, Tang Y et al (2010) Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 116(23):5507–5516

pubmed: 20672354 doi: 10.1002/cncr.25530

Serini S, Calviello G (2024) Potential of Natural Phenolic compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular mechanisms involved. Antioxidants 13(4):486

pubmed: 38671933 pmcid: 11047710 doi: 10.3390/antiox13040486

Serini S, Trombino S, Curcio F, Sole R, Cassano R, Calviello G (2023) Hyaluronic acid-mediated phenolic compound nanodelivery for cancer therapy. Pharmaceutics 15(6):1751

pubmed: 37376199 pmcid: 10302824 doi: 10.3390/pharmaceutics15061751

Shaik BB, Katari NK, Jonnalagadda SB (2022) Role of natural products in developing novel anticancer agents: a perspective. Chem Biodivers, 19(11), e202200535

Shaimerdenova M, Karapina O, Mektepbayeva D, Alibek K, Akilbekova D (2017) The effects of antiviral treatment on breast cancer cell line. Infect Agents cancer 12:1–10

doi: 10.1186/s13027-017-0128-7

Shaker FH, El-Derany MO, Wahdan SA, El-Demerdash E, El-Mesallamy HO (2021) Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats. Life sci 269:119078

pubmed: 33460662 doi: 10.1016/j.lfs.2021.119078

Siracusa R, Fusco R, Cuzzocrea S (2019) Astrocytes: role and functions in brain pathologies. Front Pharmacol 10:1114

pubmed: 31611796 pmcid: 6777416 doi: 10.3389/fphar.2019.01114

Sittl R, Lampert A, Huth T, Schuy ET, Link AS et al (2012) Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype NaV1. 6-resurgent and persistent current. Proceedings of the National Academy of Sciences 109(17), 6704–6709

Siva D, Abinaya S, Rajesh D, Archunan G, Padmanabhan P et al (2022) Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid. Nanomat 12(3):502

doi: 10.3390/nano12030502

Soares S, de Sousa JT, Boaretto FBM, da Silva JB, Dos Santos DM et al (2024) Amantadine mitigates the cytotoxic and genotoxic effects of doxorubicin in SH-SY5Y cells and reduces its mutagenicity. Toxicol in Vitro, 105874

Soffietti R, Trevisan E, Rudà R (2014) Neurologic complications of chemotherapy and other newer and experimental approaches. Handb Clin Neurol 121:1199–1218

pubmed: 24365412 doi: 10.1016/B978-0-7020-4088-7.00080-8

Stankovic JSK, Selakovic D, Mihailovic V, Rosic G (2020) Antioxidant supplementation in the treatment of neurotoxicity induced by platinum-based chemotherapeutics-a review. Int J Molec Sci 21(20):7753

doi: 10.3390/ijms21207753

Stewart DJ, Grewaal D, Green RM, Mikhael N, Goel R, Montpetit VA, Redmond MD (1993) Concentrations of doxorubicin and its metabolites in human autopsy heart and other tissues. Anticancer res 13(6A):1945–1952

pubmed: 8297100

Stone JB, DeAngelis LM (2016) Cancer-treatment-induced neurotoxicity—focus on newer treatments. Nat rev Clin Oncol 13(2):92–105

pubmed: 26391778 doi: 10.1038/nrclinonc.2015.152

Sun W, Zhong G, Kübel C, Ali FM, Qian C, Wang L et al (2017) Size-tunable photothermal germanium nanocrystals. Angew Chem Int Ed 56(22):6329–6334

doi: 10.1002/anie.201701321

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209–249

doi: 10.3322/caac.21660

Ta LE, Espeset L, Podratz J, Windebank AJ (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding. Neurotoxicology 27(6):992–1002

pubmed: 16797073 doi: 10.1016/j.neuro.2006.04.010

Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157–170

pubmed: 23278683 doi: 10.1111/j.2042-7158.2012.01567.x

Tangpong J, Cole MP, Sultana R, Joshi G et al (2006) Adriamycin-inuced, TNF-α-mediated central nervous system toxicity. Neurobiol Dis 23(1):127–139

pubmed: 16697651 doi: 10.1016/j.nbd.2006.02.013

Tangpong J, Miriyala S, Noel T, Sinthupibulyakit C, Jungsuwadee P et al (2011) Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana. Neurosci 175:292–299

doi: 10.1016/j.neuroscience.2010.11.007

Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Kamiya T et al (2012) Mechanisms of cisplatin-induced apoptosis and of cisplatin sensitivity: potential of BIN1 to act as a potent predictor of cisplatin sensitivity in gastric cancer treatment. Int J Surg Oncol 862879

Taylor OA, Hockenberry MJ, McCarthy K, Gundy P, Montgomery D et al (2015) Evaluation of biomarkers of oxidative stress and apoptosis in patients with severe methotrexate neurotoxicity: a case series. J Pediatr Oncol Nurs 32(5):320–325

pubmed: 25637187 doi: 10.1177/1043454214563409

Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI (2019) Neurotoxicity of nanomaterials: an up-to-date overview. Nanomat 9(1):96

doi: 10.3390/nano9010096

Thakur A, Sidu RK, Zou H, Alam MK, Yang M et al (2020) Inhibition of glioma cells’ proliferation by doxorubicin-loaded exosomes via microfluidics. Int J Nanomed 8331–8343

Thomas S, Sharma N, Golden EB, Cho H, Agarwal P et al (2012) Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. Cancer Lett 325(1):63–71

pubmed: 22664238 doi: 10.1016/j.canlet.2012.05.030

Thomas TC, Beitchman JA, Pomerleau F et al (2017) Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain res1672:10–17

Tian H, Cronstein BN (2007) Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bullet NYU hosp Joint Dis 65(3):168–173

Tian X, Ye J, Alonso-Basanta M, Hahn SM, Koumenis C, Dorsey JF (2011) Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 286(33):29408–29416

pubmed: 21697087 pmcid: 3190746 doi: 10.1074/jbc.M110.197665

Tian C, Yang Y, Bai B et al (2021) Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity. Int J Biol Scie 17(5):1328

doi: 10.7150/ijbs.58786

To KK, Wu X, Yin C et al (2017) Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. J Ethnopharmacol 203:110–119

pubmed: 28363522 doi: 10.1016/j.jep.2017.03.051

Tong Y, Wang K, Sheng S, Cui J (2020) Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats. Biosc Biotech Biochem 84(6):1201–1210

doi: 10.1080/09168451.2020.1722057

Tousson E, Masoud A, Elatrsh AM, Mostafa T (2016) Oral supplementation of aqueous Ginkgo biloba extract inhibits oxidative stress and hippocampus injury associated with methotrexate injection. J Biosc App Res 2(10):651–660

Uceda-Castro R, Margarido AS, Cornet L, Vegna S et al (2022) Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis. Cell Rep Med, 3(11)

Uziely B, Jeffers S, Isacson R, Kutsch K, Wei-Tsao D et al (1995) Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 13(7):1777–1785

pubmed: 7602367 doi: 10.1200/JCO.1995.13.7.1777

Vallée A, Lecarpentier Y, Guillevin R, Vallée JN (2017) Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochim Biophys Sin 49(10):853–866

pubmed: 28981597 doi: 10.1093/abbs/gmx073

Velcheti V, Punekar SR (2021) Handbook of cancer treatment-related symptoms and toxicities E-book. Elsevier Health Sciences

Verstappen CC, Heimans JJ, Hoekman K, Postma TJ (2003) Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs 63:1549–1563

pubmed: 12887262 doi: 10.2165/00003495-200363150-00003

Wahdan SA, El-Derany MO, Abdel-Maged AE, Azab SS (2020) Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: insights to neuroimmune mechanistic hallmarks. Neurochem Int 138:104777

pubmed: 32479984 doi: 10.1016/j.neuint.2020.104777

Wang K, Gao W, Dou Q, Chen H, Li Q, Nice EC, Huang C (2016) Ivermectin induces PAK1-mediated cytostatic autophagy in breast cancer. Autophagy 12(12):2498–2499

pubmed: 27657889 pmcid: 5173258 doi: 10.1080/15548627.2016.1231494

Wang L, Sun J, Gao P, Su K, Wu H, Li J, Lou W (2019) Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1/TEAD1/GLUT1 pathway. J Cell Physiol 234(9):15941–15950

pubmed: 30805937 doi: 10.1002/jcp.28253

Wang F, Zhou Y, Cheng S, Lou J et al (2020) T-modified DNA tetrahedrons loaded with doxorubicin inhibits glioma cell proliferation by targeting PDGFRβ. Nanoscale Res Lett 15:1–10

doi: 10.1186/s11671-020-03377-y

Wardill HR, Mander KA, Van Sebille YZ et al (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy‐associated neurotoxicity and cognitive dysfunction. Int J cancer 139(12):2635–2645

pubmed: 27367824 doi: 10.1002/ijc.30252

Was H, Borkowska A, Bagues A, Tu L, Liu JY et al (2022) Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol 13:750507

pubmed: 35418856 pmcid: 8996259 doi: 10.3389/fphar.2022.750507

Wefel JS, Lenzi R, Theriault R et al (2004) Chemobrain’in breast carcinoma? A prologue. Cancer: Interdisc Int J Am Cancer Soc 101(3):466–475

doi: 10.1002/cncr.20393

Weiss HD, Walker MD, Wiernik PH (1974) Neurotoxicity of commonly used antineoplastic agents. New Engl J Med 291(3):127–133

pubmed: 4365666 doi: 10.1056/NEJM197407182910305

Wisniewski T, Drummond E (2020) APOE-amyloid interaction: therapeutic targets. Neurobiol Disease 138:104784

doi: 10.1016/j.nbd.2020.104784

Wu WJ, Zhang Y, Zeng ZL, Li XB et al (2013) β-phenylethyl isothiocyanate reverses platinum resistance by a GSH-dependent mechanism in cancer cells with epithelial-mesenchymal transition phenotype. Biochem Pharmacol 85(4):486–496

pubmed: 23219523 doi: 10.1016/j.bcp.2012.11.017

Xia Y, Sun M, Huang H, Jin WL (2024) Drug repurposing for cancer therapy. Signal Transduct Target Therapy 9(1):92

doi: 10.1038/s41392-024-01808-1

Xu X, Tian K, Lou X, Du Y (2022) Potential of ferritin-based platforms for tumor immunotherapy. Molecules 27(9):2716

pubmed: 35566065 pmcid: 9104857 doi: 10.3390/molecules27092716

Yang MY, Lin PM, Liu YC, Hsiao HH, Yang WC et al (2012) Induction of cellular senescence by doxorubicin is associated with upregulated miR-375 and induction of autophagy in K562 cells. PLoS ONE, 7(5), e37205

Yang C, Hassan YI, Liu R, Zhang H, Chen Y et al (2019) Anti-inflammatory effects of different astaxanthin isomers and the roles of lipid transporters in the cellular transport of astaxanthin isomers in Caco-2 cell monolayers. J Agricult food chem 67(22):6222–6231

doi: 10.1021/acs.jafc.9b02102

Yin Q, Shen J, Chen L, Zhang Z, Gu W, Li Y (2012) Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly (β-amino esters). Biomaterials 33(27):6495–6506

pubmed: 22704597 doi: 10.1016/j.biomaterials.2012.05.039

Yue Q, Gao G, Zou G, Yu H, Zheng X (2017) Natural products as adjunctive treatment for pancreatic cancer: recent trends and advancements. BioMed res int 8412508

Zeng Q, Nie X, Li L, Liu HF, Peng YY, Zhou WT et al (2022) Salidroside promotes sensitization to doxorubicin in human cancer cells by affecting the PI3K/Akt/HIF signal pathway and inhibiting the expression of tumor-resistance-related proteins. J Nat Prod 85(1):196–204

pubmed: 34978808 doi: 10.1021/acs.jnatprod.1c00950

Zhang XF, Liu ZG, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci 17(9):1534

pubmed: 27649147 pmcid: 5037809 doi: 10.3390/ijms17091534

Zhang G, Zhang Z, Yang J (2017) DNA tetrahedron delivery enhances doxorubicin-induced apoptosis of HT-29 colon cancer cells. Nanoscale Res Lett 12:1–7

doi: 10.1186/s11671-017-2272-9

Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C (2020) Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Therapy 5(1):113

doi: 10.1038/s41392-020-00213-8

Zhang C, Jin Z, Lin Y, Wang Y, Zhao K (2023) Functionalized N-hydroxypropyl trimethylammonium chloride chitosan as an ICG/DOX co-delivery nanocarriers for targeted and chemo-photothermal combination therapy. J Drug Delivery Sci Tech 88:104920

doi: 10.1016/j.jddst.2023.104920

Zhou X, Xu P, Dang R, Guo Y, Li G et al (2018) The involvement of autophagic flux in the development and recovery of doxorubicin-induced neurotoxicity. Free Radical Bio Med 129:440–445

doi: 10.1016/j.freeradbiomed.2018.10.418

Zhu L, Li XX, Shi L, Wu J, Qian JY et al (2019) Rapamycin enhances the sensitivity of ERpositive breast cancer cells to tamoxifen by upregulating p73 expression. Oncol Rep 41(1):455–464

pubmed: 30542717

Neurotoxicity of the antineoplastic drugs: "Doxorubicin" as an example.

Journal

Informations de publication

Résumé

Identifiants

Types de publication

Langues

Sous-ensembles de citation

Informations de copyright

Références

Auteurs

Ghadha Ibrahim Fouad (G)

Maha Z Rizk (MZ)

Classifications MeSH